MANE
Veradermics, IncorporatedNYSEHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$4.37B
P/E Ratio
—
EPS
$-2.37
Beta
—
52W High
$114.50
52W Low
$32.00
50-Day MA
$64.63
200-Day MA
$60.40
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Veradermics, Incorporated
Veradermics, Incorporated is a biopharmaceutical company focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company is headquartered in New Haven, Connecticut.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -72.10% |
| Return on Assets | -43.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-163.87 |
| Price-to-Book | 16.44 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $41.48M |
| Float | $20.38M |
| % Insiders | 2.78% |
| % Institutions | 50.74% |
Historical Volatility
HV 10-Day
205.53%
HV 20-Day
163.93%
HV 30-Day
141.27%
HV 60-Day
111.20%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($126.00 target)
4
BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026